Rofecoxib: Difference between revisions
Jump to navigation
Jump to search
imported>Robert Badgett (New page: '''Rofecoxib''' is a cyclooxygenase 2 inhibitor drug used as an analgesic until it was voluntarily withdrawn from the market by Merck & Co in September, 200...) |
imported>Joe Quick m (subpages) |
||
| Line 1: | Line 1: | ||
{{subpages}} | |||
'''Rofecoxib''' is a [[cyclooxygenase 2 inhibitors|cyclooxygenase 2 inhibitor]] drug used as an analgesic until it was voluntarily withdrawn from the market by Merck & Co in September, 2004 due to increased cardiovascular complications.<ref>{{cite web |url=http://www.fda.gov/bbs/topics/news/2004/NEW01122.html |title=FDA Issues Public Health Advisory on Vioxx as its Manufacturer Voluntarily Recalls the Product |accessdate=2007-11-18 |format= |work=|year=2004}}</ref> | '''Rofecoxib''' is a [[cyclooxygenase 2 inhibitors|cyclooxygenase 2 inhibitor]] drug used as an analgesic until it was voluntarily withdrawn from the market by Merck & Co in September, 2004 due to increased cardiovascular complications.<ref>{{cite web |url=http://www.fda.gov/bbs/topics/news/2004/NEW01122.html |title=FDA Issues Public Health Advisory on Vioxx as its Manufacturer Voluntarily Recalls the Product |accessdate=2007-11-18 |format= |work=|year=2004}}</ref> | ||
| Line 4: | Line 5: | ||
==References== | ==References== | ||
<references/> | <references/> | ||
Revision as of 20:37, 21 December 2007
Rofecoxib is a cyclooxygenase 2 inhibitor drug used as an analgesic until it was voluntarily withdrawn from the market by Merck & Co in September, 2004 due to increased cardiovascular complications.[1]
References
- ↑ FDA Issues Public Health Advisory on Vioxx as its Manufacturer Voluntarily Recalls the Product (2004). Retrieved on 2007-11-18.